Definitive Contract 75D30122C14188
Award Date 6/14/22
Potential Completion Date 12/14/23
Potential Value $22M
Federal Agency
Awardee
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Tucson, AZ 85719, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The University of Arizona, doing business as the Arizona Board of Regents, has been awarded a $15 million definitive cost-no-fee contract by the Centers for Disease Control and Prevention (CDC) to conduct a COVID-19 cohort study. Under the contract, the University will serve as the prime contractor and work with subcontractor Marshfield Clinic to prospectively evaluate the immunogenicity and effectiveness of COVID-19 vaccines among previously infected and uninfected essential and frontline...
- The University of Arizona - Arizona Board of Regents was awarded a definitive cost-no-fee contract valued at approximately $7.8 million by the Centers for Disease Control and Prevention to support a prospective cohort study to assess novel approaches. The contract was awarded under the CDC's Coronavirus COVID-19 National Interest Action Code to deliver services in Tucson, Arizona from June 2020 through June 2021. As the prime contractor, the University of Arizona will leverage its expertise in...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $119,678 firm fixed price contract to the University of Arizona, doing business as the Arizona Board of Regents, for unspecified "OTHER FUNCTIONS REDUCING ANTIBACTERIAL USE". The contract, which does not have a set-aside designation, was awarded on September 30, 2017 and has a completion date of September 29, 2018. The University of Arizona is a U.S. state government entity, 1862 land grant...
- This federal contract award, valued at $1,250,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Arizona, doing business as the Arizona Board of Regents. The contract is for research and development (R&D) services and has a period of performance through April 4, 2025. The contract is a definitive, firm-fixed-price contract, with no set-aside designation. The University of Arizona is a public research university and 1862 land grant institution that...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract to the University of Arizona, doing business as the Arizona Board of Regents, for $1,250,000.00 to conduct research on Zika diagnostic testing and vector control. The contract has no set-aside designation. The University of Arizona is a public research university and 1862 land grant institution located in Tucson, Arizona. As a state government entity, higher...
- This federal contract award, valued at $267,035.00, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Arizona, doing business as the Arizona Board of Regents. The contract is a definitive, firm-fixed-price contract without a set-aside designation. It covers services related to the contract's "FOR OTHER" description, with a performance location in Tucson, Arizona. The award document indicates that the University of Arizona has extensive capabilities...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $209,409.00 firm fixed price contract to the University of Arizona (doing business as Arizona Board of Regents) for the "Rapid Diagnosis of Coccidioidomycosis". The contract, which does not have a set-aside designation, runs from September 12, 2018 to September 29, 2020. The University of Arizona, a U.S. state government entity, 1862 Land Grant College, Hispanic Serving Institution, and...
- The University of Arizona, doing business as the Arizona Board of Regents, has been awarded a $2,789,411.92 cost-type delivery order contract by the National Cancer Institute (NCI) to conduct a Phase II randomized, placebo-controlled clinical trial of the prostate cancer vaccine Prostvac (PSA-TRICOM) in patients with clinically localized prostate cancer undergoing active surveillance. This contract supports the NCI's Cancer Prevention Agent Development Program 2012-2017 and does not have a...
- The University of Arizona - doing business as Arizona Board of Regents was awarded a $428,231 definitive contract by the Department of Health and Human Services Food and Drug Administration to conduct a study titled "Yuma Valley Leafy Greens Production Area Environmental Surveillance for Bacterial Foodborne Pathogens." Per the sole source solicitation, the contractor will provide scientific expertise, field work, laboratory work and coordination to accomplish the tasks outlined in...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to the University of Arizona (doing business as the Arizona Board of Regents) for $149,997.00. The contract is for research on the long-term impact of foodborne illnesses, including associated burdens, costs, and public health implications. The University of Arizona is a U.S. state government entity, 1862 land grant college, Hispanic-serving institution, and...